Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lisena Cala"'
Autor:
Calogero D'Alessandria, Isabel Rauscher, Charlott Franz, Matthias Heck, Wolfgang A. Weber, Matthias Eiber, Andrei Gafita, Lisena Cala, Margitta Retz, Robert Tauber
Publikováno v:
Journal of Nuclear Medicine. 61:1476-1483
Prostate-specific antigen (PSA) is widely used to monitor treatment response in patients with metastatic castration-resistant prostate cancer. However, PSA measurements are considered only after 12 wk of treatment. We aimed to evaluate the prognostic
Autor:
Andrei, Gafita, Matthias M, Heck, Isabel, Rauscher, Robert, Tauber, Lisena, Cala, Charlott, Franz, Calogero, D'Alessandria, Margitta, Retz, Wolfgang A, Weber, Matthias, Eiber
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 61(10)
Prostate-specific antigen (PSA) is widely used to monitor treatment response in patients with metastatic castration-resistant prostate cancer. However, PSA measurements are considered only after 12 wk of treatment. We aimed to evaluate the prognostic
Autor:
Heribert Schunkert, Lisena Cala, Dirk Sibbing, Siegmund Braun, Petra Hoppmann, Martin Orban, Adnan Kastrati, Isabell Bernlochner, Tanja Morath, Katharina Mayer, Stefanie Schulz, Karl-Ludwig Laugwitz
Publikováno v:
Journal of the American College of Cardiology. 64(9):863-871
BACKGROUND Aspirin administration, as part of a dual antiplatelet treatment regimen, is essential for patients undergoing percutaneous coronary intervention (PCI). Although the correlation between high on-clopidogrel treatment platelet reactivity (HC
Autor:
Katharina, Mayer, Isabell, Bernlochner, Siegmund, Braun, Stefanie, Schulz, Martin, Orban, Tanja, Morath, Lisena, Cala, Petra, Hoppmann, Heribert, Schunkert, Karl-Ludwig, Laugwitz, Adnan, Kastrati, Dirk, Sibbing
Publikováno v:
Journal of the American College of Cardiology. 65(19)
Autor:
Dirk Sibbing, Siegmund Braun, Petra Hoppmann, Stefanie Schulz, Heribert Schunkert, Katharina Mayer, Karl-Ludwig Laugwitz, Lisena Cala, Martin Orban, Tanja Morath, Adnan Kastrati, Isabell Bernlochner
Publikováno v:
Journal of the American College of Cardiology. 65:2154
Background Aspirin administration, as part of a dual antiplatelet treatment regimen, is essential for patients undergoing percutaneous coronary intervention (PCI). Although the correlation between high on-clopidogrel treatment platelet reactivity (HC
Autor:
Katharina Mayer, Isabell Bernlochner, Siegmund Braun, Stefanie Schulz, Martin Orban, Tanja Morath, Lisena Cala, Petra Hoppmann, Heribert Schunkert, Laugwitz Karl-Ludwig, Adnan Kastrati, Dirk Sibbing, Deutsches Herzzentrum München, I. Medizinische Klinik
Publikováno v:
Journal of the American College of Cardiology. 63:A1721
Aspirin is integral to the antiplatelet treatment in patients undergoing percutaneous coronary intervention (PCI). The correlation between high on-clopidogrel treatment platelet reactivity (HCTPR) and clinical outcome is well established. For high on